K. Zamkoff

H. Rugo, L. Damon, P. Crilley, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Inverse relationship between constitutive gamma interferon production and human T-cell lymphoma/leukemia virus expression in cultured T lymphocytes

A. Gazdar, B. Poiesz, R. Comis, 1985, Journal of virology.

Granulocytic sarcoma presenting as bilateral adrenal masses

D. Gladstone, K. Zamkoff, B. K. Singh, 2005, American journal of hematology.

Lymphocyte response to pokeweed mitogen in chronic lymphocytic leukemia

F. Davey, H. Lamberson, K. Zamkoff, 1984, Cancer.

Infectious Complications Associated with the Use of Antithymocyte Globulin in Reduced Intensity Allogeneic Transplants

G. Russell, D. Hurd, K. Zamkoff, 2011 .

Aggressive Radiotherapy Adjuvant to Peripheral Blood Stem Cell Transplant for Relapsed Hodgkin’s Disease

J. Bogart, C. Chung, K. Zamkoff, 2000, American journal of clinical oncology.

Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin disease.

S. Ryu, J. Bogart, C. Chung, 2000, Radiology.

Case Report Idiopathic thrombocytopenic purpura and Hodgkin’s disease: report of two cases and a review of the literature

A. Gottlieb, J. Kirshner, K. Zamkoff, 1980 .

INTERLEUKIN‐2 PRODUCTION IN THE NEONATAL MOUSE

B. Argyris, K. Zamkoff, M. DeStefano, 1985, Transplantation.

Hypercalcemia with excess serum 1,25 dihydroxyvitamin D in lymphomatoid granulomatosis/angiocentric lymphoma.

S. Scheinman, A. Tatum, K. Zamkoff, 1991, The American journal of the medical sciences.

Differential effect on fresh and cultured T cells of PHA-induced changes in free cytoplasmic calcium: relation to IL-2 receptor expression, IL-2 production, and proliferation.

B. Poiesz, K. Zamkoff, L. Crespo, 1988, Cellular immunology.

The in vitro effects of vincristine on peripheral blood leukocyte progenitor cells (CFU‐C) in patients in blast crisis of chronic granulocytic leukemia: Correlation with clinical response

A. Gottlieb, F. Davey, J. Goldberg, 1983, American journal of hematology.

Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma?

Y. Keung, K. Zamkoff, D. Hurd, 2010, Bone Marrow Transplantation.

Inducible lymphokine‐activated killer (LAK) cell activity in the peripheral blood of patients with relapsed/refractory non‐Hodgkin's lymphoma (NHL)

A. Gottlieb, B. Poiesz, D. Duggan, 1990, Hematological oncology.

Use of fluorescence in situ hybridization to detect minimal residual disease in hematopoietic stem cell assays from peripheral blood stem cells of 2 patients with trisomy 8 acute myeloid leukemia.

D. Hurd, M. Pettenati, K. Zamkoff, 2004, Stem cells and development.

Cutting Edge Communication Use of Fluorescence In Situ Hybridization to Detect Minimal Residual Disease in Hematopoietic Stem Cell Assays from Peripheral Blood Stem Cells of 2 Patients with Trisomy 8 Acute Myeloid Leukemia

D. Hurd, M. Pettenati, K. Zamkoff, 2004 .

S. Bergman, D. Hurd, M. Pettenati, 2003, Bone Marrow Transplantation.

Functional diversity within the suppressor phenotype as defined by monoclonal antibody in T‐cell prolymphocytic leukemia

F. Davey, B. Poiesz, H. Lamberson, 1984, American journal of hematology.

Necrobiotic xanthogranuloma with IgA multiple myeloma: A case report and literature review

B. Streeten, K. Zamkoff, H. D. Friedman, 1990, American journal of hematology.

High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.

L. Krupp, P. Sibony, D. Gladstone, 2006, Archives of neurology.

Thrombotic thrombocytopenic purpura: Treatment with plasmapheresis

Joshua R. Smith, A. Gottlieb, S. Landaw, 1987, American journal of hematology.

Fear of cancer recurrence, distress, depressive symptoms, and quality of life in hematopoietic stem cell transplantation patients

M. Andrykowski, G. Russell, D. Hurd, 2019, Journal of Psychosocial Oncology Research & Practice.

T-cell prolymphocytic leukemia with a suppressor phenotype.

F. Davey, B. Poiesz, K. Zamkoff, 1983, Annals of clinical and laboratory science.

Diminished autologous mixed lymphocyte reaction in patients with hodgkin disease: Evidence for non‐t cell dysfunction

F. Davey, K. Zamkoff, N. Dock, 1982, American journal of hematology.

Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil

M. Golightly, D. Gladstone, K. Zamkoff, 2005, Rheumatology International.

A phase I trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy.

A. Rudolph, B. Poiesz, N. Newman, 1989, Journal of biological response modifiers.

A phase II study of recombinant interleukin-2 with or without recombinant interferon-beta in non-Hodgkin's lymphoma. A study of the Cancer and Leukemia Group B.

C. Bloomfield, B. Peterson, B. Poiesz, 1992, Journal of immunotherapy.

Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.

B. Poiesz, R. Comis, W. G. Reeves, 1985, Clinical immunology and immunopathology.

Idiopathic thrombocytopenic purpura and Hodgkin's disease: report of two cases and a review of the literature.

A. Gottlieb, J. Kirshner, K. Zamkoff, 1980, The American journal of the medical sciences.

Acute nonlymphocytic leukemia complicated by severe cytophagocytosis of formed blood elements by nonmalignant histiocytes: cause of significant clinical morbidity.

A. Gottlieb, F. Davey, S. Ginsberg, 1983, Medical and pediatric oncology.

Thyrotoxic thyroiditis after radiotherapy for Hodgkin's disease.

A. Gottlieb, C. Chung, K. Zamkoff, 1985, Archives of internal medicine.

Phase I trial of recombinant interleukin-2 and recombinant beta-interferon in refractory neoplastic diseases.

A. Rudolph, A. Scalzo, B. Poiesz, 1989, Journal of biological response modifiers.